Melton (Shen Zhen) Biomedical Technology CompanyLi mited – Trademark Portfolio
Entity Type: 16
Melton (Shen Zhen) Biomedical Technology CompanyLi mited has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). The portfolio includes 0 registered trademarks and 1 pending application. Filings span 3 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 1 (Chemicals). This trademark owner is based in Shenzhen.
606A-10, Bldg. 8, Qianhai Center,
Unit 2, Guiwan Dist., Nanshan St.,
Shenzhen 430000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Melton (Shen Zhen) Biomedical Technology CompanyLi mited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Melton (Shen Zhen) Biomedical Technology CompanyLi mited have?
Melton (Shen Zhen) Biomedical Technology CompanyLi mited has 3 U.S. trademarks filed with the USPTO. Of these, 1 pending, 2 abandoned.
What trademark classes does Melton (Shen Zhen) Biomedical Technology CompanyLi mited file in?
Melton (Shen Zhen) Biomedical Technology CompanyLi mited files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What is Melton (Shen Zhen) Biomedical Technology CompanyLi mited's trademark registration success rate?
Melton (Shen Zhen) Biomedical Technology CompanyLi mited has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.